FibroGen Inc
NASDAQ:KYNB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
FibroGen Inc
NASDAQ:KYNB
|
US |
|
G
|
GAM Holding AG
XHAM:GAD
|
CH |
|
Sandvik AB
F:SVK
|
SE |
|
S
|
SM Energy Co
SWB:SJL
|
US |
|
P
|
Panasonic Holdings Corp
XBER:MAT1
|
JP |
|
C
|
Conocophillips
XMUN:YCP
|
US |
|
Aura Biosciences Inc
NASDAQ:AURA
|
US |
|
Y
|
Yum! Brands Inc
SWB:TGR
|
US |
|
S
|
Sealed Air Corp
DUS:SDA
|
US |
|
T
|
Tesco PLC
OTC:TSCDF
|
UK |
|
A
|
AdCapital AG
DUS:ADC
|
DE |
|
A
|
AT&T Inc
XBER:SOBA
|
US |
|
T
|
Truist Financial Corp
SWB:BBK
|
US |
|
S
|
Stellantis NV
DUS:8TI
|
NL |
|
F
|
Federal Realty Investment Trust
F:WX2
|
US |
|
C
|
CNH Industrial NV
VSE:CNHI
|
UK |
|
H
|
HWA AG
XBER:H9W
|
DE |
|
C
|
Celestica Inc
XMUN:CTW
|
CA |
|
Deoleo SA
F:SC5A
|
ES |
|
C
|
Ceconomy AG
OTC:MTTRY
|
DE |
|
A
|
Akwel SA
F:MW4
|
FR |
|
First Financial Corp
NASDAQ:THFF
|
US |
Wall St Price Targets
KYNB Price Targets Summary
FibroGen Inc
According to Wall Street analysts, the average 1-year price target for
KYNB is 43.86 USD with a low forecast of 43.43 USD and a high forecast of 45.15 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is KYNB's stock price target?
Price Target
43.86
USD
According to Wall Street analysts, the average 1-year price target for
KYNB is 43.86 USD with a low forecast of 43.43 USD and a high forecast of 45.15 USD.
What is the Revenue forecast for FibroGen Inc?
Projected CAGR
-32%
Over the last 11 years, the compound annual growth rate for Revenue has been -11%. The projected CAGR for the next 4 years is -32%.